On Aug. 21, 2025, Johnson & Johnson announced it will increase its presence in North Carolina with a 160,000+ square foot dedicated manufacturing facility at FUJIFILM’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina. The $2 billion commitment to FUJIFILM over the next 10 years will expand the Company’s U.S. manufacturing capacity and create approximately 120 new jobs in North Carolina.

In the coming months, the Company also intends to share the plans for additional advanced manufacturing facilities in the U.S. as well as the expansion of current U.S. sites. These plans reinforce Johnson & Johnson’s leadership in delivering cutting-edge healthcare solutions and will enable the Company to manufacture the vast majority of our advanced medicines in the U.S. to meet the needs of U.S. patients.

Progress continues in the construction of the Wilson, North Carolina facility, which will employ more than 500 people when fully operational and create approximately 5,000 construction jobs during the site development.